Discovery of New Antigens
Since antigens were first successfully used to stimulate the immune system to produce antibodies, scientists have achieved significant breakthroughs in antigen research. Recently, a novel discovery of antigens has not only deepened our understanding of antigens and immune responses but also holds promising implications for vaccine development and immunotherapy.
1. Introduction to Antigens
Antigens are substances that can induce immune responses and bind to specific immune effectors such as antibodies or T-cell receptors. They are typically found in pathogenic microorganisms, including bacteria, viruses, and parasites. However, recent research indicates that normal cells in our body can also produce antigens.
2. Discovery of Neoantigens
A team of international scientists has discovered a new class of antigens known as "neoantigens." These neoantigens arise from mutations in normal cells within our bodies. When cells undergo mutations leading to diseases like cancer, neoantigens emerge. Importantly, neoantigens are highly individualized, varying from person to person, which potentially allows for personalized vaccine and immunotherapy strategies.
3. New Prospects for Vaccines and Therapies
The understanding of neoantigens paves the way for scientists to develop more targeted and effective vaccines and immunotherapies. For example, scientists can create personalized vaccine or immunotherapy protocols tailored to an individual's neoantigens, thereby enhancing therapeutic outcomes. Additionally, insights into neoantigens can aid in uncovering novel immune response mechanisms, significantly contributing to a deeper understanding of the immune system and the development of innovative approaches to disease prevention and treatment.
MtoZ Biolabs, an integrated chromatography and mass spectrometry (MS) services provider.
Related Services
How to order?
